NCT06214338View on ClinicalTrials.gov

Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β)

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 12, 2024

Primary Completion Date

March 18, 2024

Study Completion Date

April 15, 2024

Conditions
Bioavailability
Interventions
DIETARY_SUPPLEMENT

Low dose

Consumption of a β-alanine sustained-release supplement, 10 mg by 4 intakes of 2.5, separated by 1 hour and 15 min.

DIETARY_SUPPLEMENT

High dose

Consumption of a β-alanine sustained-release supplement, 10 mg by 4 intakes of 5 separated by 1 hour and 15 min.

Trial Locations (1)

30107

Catholic University of Murcia, Murcia

All Listed Sponsors
lead

Universidad Católica San Antonio de Murcia

OTHER

NCT06214338 - Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β) | Biotech Hunter | Biotech Hunter